Somewhat Positive Press Coverage Somewhat Unlikely to Affect Mazor Robotics (MZOR) Stock Price

Media headlines about Mazor Robotics (NASDAQ:MZOR) have trended somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Mazor Robotics earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned news coverage about the medical instruments supplier an impact score of 47.4460832934154 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Mazor Robotics opened at $57.93 on Friday, MarketBeat.com reports. The company has a market cap of $1.50 billion, a price-to-earnings ratio of -115.86 and a beta of 1.22. Mazor Robotics has a 52-week low of $29.55 and a 52-week high of $76.56.

Mazor Robotics (NASDAQ:MZOR) last released its earnings results on Monday, May 14th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.02. The company had revenue of $15.51 million for the quarter, compared to analyst estimates of $15.13 million. Mazor Robotics had a negative net margin of 12.14% and a negative return on equity of 8.08%. The firm’s quarterly revenue was up 32.3% on a year-over-year basis. During the same period in the prior year, the business earned ($0.08) EPS. equities analysts predict that Mazor Robotics will post 0.06 earnings per share for the current year.



MZOR has been the subject of a number of research analyst reports. Vetr raised shares of Mazor Robotics from a “hold” rating to a “buy” rating and set a $66.27 price objective for the company in a research report on Thursday, March 1st. Zacks Investment Research cut shares of Mazor Robotics from a “buy” rating to a “hold” rating in a research report on Thursday, February 8th. BidaskClub raised shares of Mazor Robotics from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, March 14th. Needham & Company LLC cut shares of Mazor Robotics from a “hold” rating to an “underperform” rating in a research report on Friday, March 16th. Finally, Wells Fargo & Co increased their target price on shares of Mazor Robotics from $56.00 to $62.00 and gave the stock a “market perform” rating in a report on Tuesday, May 15th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $61.90.

About Mazor Robotics

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness.

Insider Buying and Selling by Quarter for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply